TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
AVXL

Anavex Life Sciences Corp

Healthcare · Biotechnology

2.40$ +0.4% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Anavex Life Sciences Corp (AVXL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.9% of the shares are freely tradable; institutional investors hold 43.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 43.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 3.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 96.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 15.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 93Mio.

Largest Shareholders

Institutions

Institutions AVXL
Name Stake (%) Shares Change (%) Date
BlackRock Inc 8.21 7,609,618 +1.1 03/31/2026
State Street Corp 4.87 4,512,028 +2.9 03/31/2026
Vanguard Capital Management, LLC 4.17 3,863,950 +0.0 03/31/2026
Two Sigma Investments LLC 3.29 3,046,538 -6.2 06/30/2026
Geode Capital Management, LLC 2.36 2,188,275 +8.2 03/31/2026
Federated Hermes Inc 1.16 1,071,809 +101.4 06/30/2026

Funds

Funds AVXL
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.16 2,925,439 +0.0 07/31/2026
iShares Russell 2000 ETF 2.57 2,381,628 -0.6 08/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 1.17 1,081,833 +3.9 07/31/2026
Federated Hermes MDT Small Cap Core IS 1.15 1,068,872 +103.1 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?